Annual Income Statements for Bain Capital Specialty Finance
This table shows Bain Capital Specialty Finance's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.
Quarterly Income Statements for Bain Capital Specialty Finance
This table shows Bain Capital Specialty Finance's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.
Metric |
|
Q4 2022 |
Q1 2023 |
Q2 2023 |
Q3 2023 |
Q4 2023 |
Q1 2024 |
Q2 2024 |
Q3 2024 |
Q4 2024 |
Q1 2025 |
Q2 2025 |
Net Income / (Loss) Attributable to Common Shareholders |
|
62 |
-5.27 |
29 |
-38 |
-9.91 |
35 |
29 |
33 |
22 |
-34 |
24 |
Consolidated Net Income / (Loss) |
|
74 |
-5.27 |
37 |
-38 |
-18 |
39 |
28 |
31 |
34 |
-34 |
19 |
Net Income / (Loss) Continuing Operations |
|
65 |
-5.27 |
37 |
-38 |
-18 |
39 |
28 |
31 |
34 |
-34 |
19 |
Total Pre-Tax Income |
|
65 |
-5.27 |
37 |
-38 |
-18 |
39 |
28 |
31 |
34 |
-34 |
19 |
Total Revenue |
|
101 |
-2.85 |
53 |
-34 |
-28 |
62 |
49 |
52 |
53 |
-31 |
37 |
Net Interest Income / (Expense) |
|
103 |
-20 |
38 |
-21 |
-77 |
38 |
37 |
37 |
35 |
-19 |
32 |
Total Interest Income |
|
130 |
0.00 |
58 |
0.00 |
-58 |
56 |
55 |
55 |
56 |
0.00 |
54 |
Investment Securities Interest Income |
|
- |
- |
58 |
- |
- |
56 |
55 |
55 |
56 |
- |
54 |
Total Interest Expense |
|
27 |
20 |
20 |
21 |
19 |
18 |
18 |
18 |
21 |
19 |
22 |
Long-Term Debt Interest Expense |
|
- |
20 |
20 |
21 |
19 |
18 |
18 |
18 |
21 |
19 |
22 |
Total Non-Interest Income |
|
-1.99 |
17 |
16 |
-14 |
49 |
24 |
12 |
14 |
18 |
-12 |
5.02 |
Other Service Charges |
|
2.61 |
5.25 |
1.92 |
1.01 |
2.38 |
5.26 |
3.14 |
5.70 |
4.50 |
2.88 |
4.16 |
Net Realized & Unrealized Capital Gains on Investments |
|
-36 |
11 |
-2.03 |
-15 |
62 |
5.17 |
-5.45 |
-2.89 |
0.47 |
-15 |
-12 |
Other Non-Interest Income |
|
- |
- |
16 |
- |
- |
14 |
14 |
11 |
13 |
- |
13 |
Total Non-Interest Expense |
|
34 |
2.41 |
16 |
3.18 |
-11 |
22 |
22 |
20 |
19 |
3.46 |
19 |
Insurance Policy Acquisition Costs |
|
- |
- |
4.01 |
- |
- |
9.23 |
7.92 |
7.02 |
4.70 |
- |
5.45 |
Other Operating Expenses |
|
30 |
2.41 |
12 |
3.18 |
-6.67 |
13 |
14 |
13 |
14 |
3.46 |
13 |
Basic Earnings per Share |
|
$0.67 |
$0.45 |
$0.45 |
$0.52 |
$0.49 |
$0.55 |
$0.45 |
$0.51 |
$0.34 |
$0.44 |
$0.37 |
Weighted Average Basic Shares Outstanding |
|
64.56M |
64.56M |
64.56M |
64.56M |
64.56M |
64.56M |
64.56M |
64.56M |
64.56M |
64.68M |
64.87M |
Diluted Earnings per Share |
|
- |
$0.45 |
$0.45 |
$0.52 |
$0.49 |
$0.55 |
$0.45 |
$0.51 |
$0.34 |
$0.44 |
$0.37 |
Weighted Average Diluted Shares Outstanding |
|
64.56M |
64.56M |
64.56M |
64.56M |
64.56M |
64.56M |
64.56M |
64.56M |
64.56M |
64.68M |
64.87M |
Basic & Diluted Earnings per Share |
|
- |
- |
- |
- |
- |
- |
$0.51 |
- |
- |
- |
$0.47 |
Weighted Average Basic & Diluted Shares Outstanding |
|
64.56M |
64.56M |
64.56M |
64.56M |
64.56M |
64.56M |
64.56M |
64.56M |
64.61M |
64.87M |
64.87M |
Annual Cash Flow Statements for Bain Capital Specialty Finance
This table details how cash moves in and out of Bain Capital Specialty Finance's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.
Metric |
|
2020 |
2021 |
2022 |
2023 |
2024 |
Net Change in Cash & Equivalents |
|
13 |
127 |
-79 |
-12 |
-13 |
Net Cash From Operating Activities |
|
89 |
266 |
-317 |
219 |
-27 |
Net Cash From Continuing Operating Activities |
|
89 |
266 |
-317 |
218 |
-27 |
Net Income / (Loss) Continuing Operations |
|
8.28 |
120 |
105 |
123 |
119 |
Consolidated Net Income / (Loss) |
|
8.28 |
120 |
105 |
123 |
119 |
Amortization Expense |
|
-3.23 |
0.06 |
-1.04 |
-1.76 |
-1.13 |
Non-Cash Adjustments to Reconcile Net Income |
|
78 |
167 |
-393 |
110 |
-125 |
Changes in Operating Assets and Liabilities, net |
|
-22 |
-21 |
-28 |
-14 |
-21 |
Net Cash From Investing Activities |
|
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
Net Cash From Continuing Investing Activities |
|
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
Net Cash From Financing Activities |
|
-77 |
-139 |
238 |
-231 |
14 |
Net Cash From Continuing Financing Activities |
|
-77 |
-139 |
238 |
-231 |
14 |
Issuance of Debt |
|
597 |
1,425 |
793 |
348 |
867 |
Repayment of Debt |
|
-716 |
-1,476 |
-467 |
-480 |
-738 |
Payment of Dividends |
|
-86 |
-88 |
-88 |
-99 |
-114 |
Cash Interest Paid |
|
68 |
47 |
43 |
75 |
70 |
Cash Income Taxes Paid |
|
0.00 |
0.24 |
0.13 |
1.22 |
2.25 |
Quarterly Cash Flow Statements for Bain Capital Specialty Finance
This table details how cash moves in and out of Bain Capital Specialty Finance's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.
Metric |
|
Q4 2022 |
Q1 2023 |
Q2 2023 |
Q3 2023 |
Q4 2023 |
Q1 2024 |
Q2 2024 |
Q3 2024 |
Q4 2024 |
Q1 2025 |
Q2 2025 |
Net Change in Cash & Equivalents |
|
66 |
-44 |
48 |
-22 |
6.57 |
10 |
-24 |
-39 |
40 |
-5.29 |
78 |
Net Cash From Operating Activities |
|
63 |
-43 |
-8.77 |
122 |
149 |
-64 |
192 |
-136 |
-20 |
-7.27 |
0.65 |
Net Cash From Continuing Operating Activities |
|
63 |
-43 |
-8.77 |
122 |
148 |
-64 |
193 |
-136 |
-20 |
-7.27 |
0.65 |
Net Income / (Loss) Continuing Operations |
|
44 |
29 |
29 |
34 |
31 |
35 |
29 |
33 |
22 |
29 |
24 |
Consolidated Net Income / (Loss) |
|
44 |
29 |
29 |
34 |
31 |
35 |
29 |
33 |
22 |
29 |
24 |
Amortization Expense |
|
-0.30 |
-0.90 |
-0.49 |
-0.37 |
-0.01 |
-0.58 |
-0.09 |
-0.03 |
-0.43 |
-0.41 |
0.05 |
Non-Cash Adjustments to Reconcile Net Income |
|
36 |
-72 |
-27 |
90 |
119 |
-102 |
174 |
-161 |
-34 |
-49 |
-6.65 |
Changes in Operating Assets and Liabilities, net |
|
-16 |
0.63 |
-10 |
-1.09 |
-2.76 |
3.49 |
-11 |
-7.48 |
-7.87 |
14 |
-16 |
Net Cash From Financing Activities |
|
2.79 |
-1.24 |
56 |
-145 |
-142 |
74 |
-217 |
97 |
60 |
1.98 |
78 |
Net Cash From Continuing Financing Activities |
|
2.79 |
-1.24 |
56 |
-145 |
-142 |
74 |
-217 |
97 |
60 |
1.98 |
78 |
Issuance of Debt |
|
65 |
155 |
153 |
20 |
20 |
198 |
99 |
268 |
302 |
459 |
300 |
Repayment of Debt |
|
-40 |
-133 |
-72 |
-140 |
-135 |
-97 |
-286 |
-142 |
-213 |
-404 |
-193 |
Payment of Dividends |
|
-22 |
-23 |
-25 |
-25 |
-27 |
-27 |
-29 |
-29 |
-29 |
-58 |
-29 |
Cash Interest Paid |
|
13 |
17 |
18 |
21 |
20 |
18 |
18 |
16 |
19 |
20 |
18 |
Annual Balance Sheets for Bain Capital Specialty Finance
This table presents Bain Capital Specialty Finance's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.
Metric |
2021 |
2022 |
2023 |
2024 |
Total Assets |
2,571 |
2,592 |
2,472 |
2,632 |
Cash and Due from Banks |
117 |
30 |
43 |
52 |
Restricted Cash |
86 |
66 |
63 |
46 |
Trading Account Securities |
5.32 |
0.06 |
0.00 |
2,436 |
Loans and Leases, Net of Allowance |
0.00 |
0.00 |
0.00 |
0.00 |
Other Assets |
77 |
100 |
2,351 |
83 |
Total Liabilities & Shareholders' Equity |
2,571 |
2,592 |
2,472 |
2,632 |
Total Liabilities |
1,471 |
1,476 |
1,336 |
1,492 |
Accrued Interest Payable |
7.06 |
12 |
13 |
14 |
Other Short-Term Payables |
- |
- |
- |
15 |
Long-Term Debt |
1,415 |
1,385 |
1,256 |
1,390 |
Other Long-Term Liabilities |
49 |
79 |
48 |
60 |
Commitments & Contingencies |
0.00 |
0.00 |
0.00 |
0.00 |
Total Equity & Noncontrolling Interests |
1,100 |
1,116 |
1,136 |
1,140 |
Total Preferred & Common Equity |
1,100 |
1,116 |
1,136 |
1,140 |
Total Common Equity |
1,168 |
1,116 |
1,136 |
1,140 |
Common Stock |
1,168 |
1,168 |
1,168 |
1,160 |
Retained Earnings |
- |
-52 |
-32 |
-20 |
Quarterly Balance Sheets for Bain Capital Specialty Finance
This table presents Bain Capital Specialty Finance's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.
Metric |
|
Q3 2022 |
Q1 2023 |
Q2 2023 |
Q3 2023 |
Q1 2024 |
Q2 2024 |
Q3 2024 |
Q1 2025 |
Q2 2025 |
Total Assets |
|
4.53 |
2,606 |
2,675 |
2,566 |
2,580 |
2,415 |
2,544 |
2,642 |
2,774 |
Cash and Due from Banks |
|
- |
23 |
88 |
65 |
47 |
18 |
25 |
10 |
28 |
Restricted Cash |
|
- |
51 |
36 |
26 |
74 |
67 |
29 |
56 |
137 |
Trading Account Securities |
|
- |
1.11 |
0.06 |
5.85 |
0.92 |
0.65 |
- |
1.47 |
0.00 |
Loans and Leases, Net of Allowance |
|
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
Deferred Acquisition Cost |
|
- |
3.51 |
3.28 |
3.04 |
2.57 |
5.12 |
4.86 |
4.33 |
4.07 |
Other Assets |
|
4.53 |
125 |
161 |
2,443 |
2,449 |
91 |
77 |
2,509 |
105 |
Total Liabilities & Shareholders' Equity |
|
0.00 |
2,606 |
2,675 |
2,566 |
2,580 |
2,415 |
2,544 |
2,642 |
2,774 |
Total Liabilities |
|
0.00 |
1,485 |
1,550 |
1,434 |
1,438 |
1,272 |
1,397 |
1,498 |
1,635 |
Accrued Interest Payable |
|
- |
14 |
16 |
15 |
13 |
12 |
13 |
12 |
14 |
Long-Term Debt |
|
- |
1,408 |
1,490 |
1,370 |
1,358 |
1,174 |
1,301 |
1,451 |
1,563 |
Other Long-Term Liabilities |
|
- |
63 |
44 |
42 |
49 |
87 |
83 |
25 |
59 |
Commitments & Contingencies |
|
- |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
Total Equity & Noncontrolling Interests |
|
0.00 |
1,168 |
1,126 |
1,133 |
1,143 |
1,143 |
1,147 |
1,145 |
1,139 |
Total Preferred & Common Equity |
|
0.00 |
1,121 |
1,126 |
1,133 |
1,143 |
1,143 |
1,147 |
1,145 |
1,139 |
Total Common Equity |
|
0.00 |
1,168 |
1,126 |
1,133 |
1,143 |
1,143 |
1,147 |
1,145 |
1,139 |
Common Stock |
|
- |
1,168 |
1,168 |
1,168 |
1,165 |
1,165 |
1,165 |
1,164 |
1,164 |
Retained Earnings |
|
- |
- |
-43 |
-36 |
-23 |
-23 |
-19 |
-20 |
-25 |
Annual Metrics And Ratios for Bain Capital Specialty Finance
This table displays calculated financial ratios and metrics derived from Bain Capital Specialty Finance's official financial filings.
Metric |
|
2020 |
2021 |
2022 |
2023 |
2024 |
Growth Metrics |
|
- |
- |
- |
- |
- |
Revenue Growth |
|
0.00% |
481.63% |
13.00% |
-106.66% |
1,854.77% |
EBITDA Growth |
|
0.00% |
563.96% |
13.26% |
-121.30% |
617.59% |
EBIT Growth |
|
0.00% |
321.00% |
14.31% |
-119.64% |
661.08% |
NOPAT Growth |
|
0.00% |
415.72% |
14.31% |
-113.75% |
901.54% |
Net Income Growth |
|
0.00% |
321.00% |
14.31% |
-119.64% |
661.08% |
EPS Growth |
|
0.00% |
1,228.57% |
-12.37% |
17.18% |
-3.14% |
Operating Cash Flow Growth |
|
0.00% |
196.98% |
-219.31% |
169.21% |
-112.36% |
Free Cash Flow Firm Growth |
|
0.00% |
0.00% |
105.52% |
-30.24% |
-105.97% |
Invested Capital Growth |
|
0.00% |
0.00% |
-0.53% |
-4.37% |
5.75% |
Revenue Q/Q Growth |
|
0.00% |
0.00% |
0.00% |
-110.47% |
60.59% |
EBITDA Q/Q Growth |
|
0.00% |
0.00% |
0.00% |
-142.75% |
64.46% |
EBIT Q/Q Growth |
|
0.00% |
0.00% |
0.00% |
-138.44% |
64.43% |
NOPAT Q/Q Growth |
|
0.00% |
0.00% |
0.00% |
-127.93% |
64.43% |
Net Income Q/Q Growth |
|
0.00% |
0.00% |
0.00% |
-134.37% |
64.43% |
EPS Q/Q Growth |
|
0.00% |
0.00% |
0.00% |
0.00% |
-7.50% |
Operating Cash Flow Q/Q Growth |
|
0.00% |
0.00% |
-1.95% |
64.08% |
-119.14% |
Free Cash Flow Firm Q/Q Growth |
|
0.00% |
0.00% |
0.00% |
0.00% |
-104.08% |
Invested Capital Q/Q Growth |
|
0.00% |
0.00% |
0.00% |
-4.41% |
3.38% |
Profitability Metrics |
|
- |
- |
- |
- |
- |
EBITDA Margin |
|
0.00% |
64.28% |
64.42% |
0.00% |
60.79% |
EBIT Margin |
|
0.00% |
64.24% |
64.99% |
0.00% |
61.31% |
Profit (Net Income) Margin |
|
0.00% |
64.24% |
64.99% |
0.00% |
61.31% |
Tax Burden Percent |
|
100.00% |
100.00% |
100.00% |
100.00% |
100.00% |
Interest Burden Percent |
|
100.00% |
100.00% |
100.00% |
100.00% |
100.00% |
Effective Tax Rate |
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
Return on Invested Capital (ROIC) |
|
0.00% |
8.33% |
4.77% |
0.00% |
5.36% |
ROIC Less NNEP Spread (ROIC-NNEP) |
|
0.00% |
8.33% |
4.77% |
0.00% |
5.36% |
Return on Net Nonoperating Assets (RNNOA) |
|
0.00% |
10.72% |
6.03% |
0.00% |
6.24% |
Return on Equity (ROE) |
|
0.00% |
19.05% |
10.81% |
-2.09% |
11.60% |
Cash Return on Invested Capital (CROIC) |
|
0.00% |
-191.67% |
5.30% |
3.79% |
-0.23% |
Operating Return on Assets (OROA) |
|
0.00% |
4.07% |
4.64% |
0.00% |
5.17% |
Return on Assets (ROA) |
|
0.00% |
4.07% |
4.64% |
0.00% |
5.17% |
Return on Common Equity (ROCE) |
|
0.00% |
20.23% |
11.14% |
-2.09% |
11.60% |
Return on Equity Simple (ROE_SIMPLE) |
|
0.00% |
9.52% |
10.73% |
-2.07% |
11.58% |
Net Operating Profit after Tax (NOPAT) |
|
-33 |
105 |
120 |
-16 |
132 |
NOPAT Margin |
|
0.00% |
64.24% |
64.99% |
0.00% |
61.31% |
Net Nonoperating Expense Percent (NNEP) |
|
0.00% |
0.00% |
0.00% |
0.53% |
0.00% |
SG&A Expenses to Revenue |
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
Operating Expenses to Revenue |
|
0.00% |
35.76% |
35.01% |
0.00% |
38.69% |
Earnings before Interest and Taxes (EBIT) |
|
-47 |
105 |
120 |
-24 |
132 |
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA) |
|
-23 |
105 |
119 |
-25 |
131 |
Valuation Ratios |
|
- |
- |
- |
- |
- |
Price to Book Value (P/BV) |
|
0.00 |
0.00 |
0.54 |
0.75 |
0.97 |
Price to Tangible Book Value (P/TBV) |
|
0.00 |
0.00 |
0.54 |
0.75 |
0.97 |
Price to Revenue (P/Rev) |
|
0.00 |
0.00 |
3.25 |
0.00 |
5.11 |
Price to Earnings (P/E) |
|
0.00 |
0.00 |
5.68 |
0.00 |
9.22 |
Dividend Yield |
|
18.31% |
12.71% |
14.88% |
12.15% |
8.09% |
Earnings Yield |
|
0.00% |
0.00% |
17.62% |
0.00% |
10.85% |
Enterprise Value to Invested Capital (EV/IC) |
|
0.00 |
0.00 |
0.75 |
0.84 |
0.95 |
Enterprise Value to Revenue (EV/Rev) |
|
0.00 |
0.00 |
10.24 |
0.00 |
11.12 |
Enterprise Value to EBITDA (EV/EBITDA) |
|
0.00 |
0.00 |
15.90 |
0.00 |
18.29 |
Enterprise Value to EBIT (EV/EBIT) |
|
0.00 |
0.00 |
15.76 |
0.00 |
18.13 |
Enterprise Value to NOPAT (EV/NOPAT) |
|
0.00 |
0.00 |
15.76 |
0.00 |
18.13 |
Enterprise Value to Operating Cash Flow (EV/OCF) |
|
0.00 |
0.00 |
0.00 |
9.12 |
0.00 |
Enterprise Value to Free Cash Flow (EV/FCFF) |
|
0.00 |
0.00 |
14.19 |
21.54 |
0.00 |
Leverage & Solvency |
|
- |
- |
- |
- |
- |
Debt to Equity |
|
0.00 |
1.29 |
1.24 |
1.11 |
1.22 |
Long-Term Debt to Equity |
|
0.00 |
1.29 |
1.24 |
1.11 |
1.22 |
Financial Leverage |
|
0.00 |
1.29 |
1.26 |
1.17 |
1.16 |
Leverage Ratio |
|
0.00 |
2.34 |
2.33 |
2.25 |
2.24 |
Compound Leverage Factor |
|
0.00 |
2.34 |
2.33 |
2.25 |
2.24 |
Debt to Total Capital |
|
0.00% |
56.26% |
55.37% |
52.50% |
54.95% |
Short-Term Debt to Total Capital |
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
Long-Term Debt to Total Capital |
|
0.00% |
56.26% |
55.37% |
52.50% |
54.95% |
Preferred Equity to Total Capital |
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
Noncontrolling Interests to Total Capital |
|
0.00% |
-2.72% |
0.00% |
0.00% |
0.00% |
Common Equity to Total Capital |
|
0.00% |
46.46% |
44.63% |
47.50% |
45.05% |
Debt to EBITDA |
|
0.00 |
13.50 |
11.67 |
-49.67 |
10.62 |
Net Debt to EBITDA |
|
0.00 |
11.56 |
10.86 |
-45.47 |
9.88 |
Long-Term Debt to EBITDA |
|
0.00 |
13.50 |
11.67 |
-49.67 |
10.62 |
Debt to NOPAT |
|
0.00 |
13.51 |
11.57 |
-76.26 |
10.53 |
Net Debt to NOPAT |
|
0.00 |
11.56 |
10.76 |
-69.82 |
9.80 |
Long-Term Debt to NOPAT |
|
0.00 |
13.51 |
11.57 |
-76.26 |
10.53 |
Noncontrolling Interest Sharing Ratio |
|
0.00% |
-6.22% |
-3.09% |
0.00% |
0.00% |
Liquidity Ratios |
|
- |
- |
- |
- |
- |
Cash Flow Metrics |
|
- |
- |
- |
- |
- |
Free Cash Flow to Firm (FCFF) |
|
0.00 |
-2,410 |
133 |
93 |
-5.54 |
Operating Cash Flow to CapEx |
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
Free Cash Flow to Firm to Interest Expense |
|
0.00 |
-46.94 |
2.54 |
1.16 |
-0.07 |
Operating Cash Flow to Interest Expense |
|
1.41 |
5.17 |
-6.06 |
2.74 |
-0.36 |
Operating Cash Flow Less CapEx to Interest Expense |
|
1.41 |
5.17 |
-6.06 |
2.74 |
-0.36 |
Efficiency Ratios |
|
- |
- |
- |
- |
- |
Asset Turnover |
|
0.00 |
0.06 |
0.07 |
0.00 |
0.08 |
Fixed Asset Turnover |
|
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
Capital & Investment Metrics |
|
- |
- |
- |
- |
- |
Invested Capital |
|
0.00 |
2,515 |
2,502 |
2,392 |
2,530 |
Invested Capital Turnover |
|
0.00 |
0.13 |
0.07 |
0.00 |
0.09 |
Increase / (Decrease) in Invested Capital |
|
0.00 |
2,515 |
-13 |
-109 |
138 |
Enterprise Value (EV) |
|
0.00 |
0.00 |
1,888 |
2,000 |
2,394 |
Market Capitalization |
|
0.00 |
0.00 |
599 |
850 |
1,101 |
Book Value per Share |
|
$0.00 |
$18.10 |
$17.29 |
$17.60 |
$17.65 |
Tangible Book Value per Share |
|
$0.00 |
$18.10 |
$17.29 |
$17.60 |
$17.65 |
Total Capital |
|
0.00 |
2,515 |
2,502 |
2,392 |
2,530 |
Total Debt |
|
0.00 |
1,415 |
1,385 |
1,256 |
1,390 |
Total Long-Term Debt |
|
0.00 |
1,415 |
1,385 |
1,256 |
1,390 |
Net Debt |
|
0.00 |
1,211 |
1,289 |
1,150 |
1,293 |
Capital Expenditures (CapEx) |
|
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
Net Nonoperating Expense (NNE) |
|
14 |
0.00 |
0.00 |
7.06 |
0.00 |
Net Nonoperating Obligations (NNO) |
|
0.00 |
1,415 |
1,385 |
1,256 |
1,390 |
Total Depreciation and Amortization (D&A) |
|
25 |
0.06 |
-1.04 |
-1.76 |
-1.13 |
Earnings Adjustments |
|
- |
- |
- |
- |
- |
Adjusted Basic Earnings per Share |
|
$0.00 |
$0.00 |
$1.63 |
$1.91 |
$1.85 |
Adjusted Weighted Average Basic Shares Outstanding |
|
0.00 |
0.00 |
64.56M |
64.56M |
64.56M |
Adjusted Diluted Earnings per Share |
|
$0.00 |
$0.00 |
$1.63 |
$1.91 |
$1.85 |
Adjusted Weighted Average Diluted Shares Outstanding |
|
0.00 |
0.00 |
64.56M |
64.56M |
64.56M |
Adjusted Basic & Diluted Earnings per Share |
|
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
Adjusted Weighted Average Basic & Diluted Shares Outstanding |
|
0.00 |
0.00 |
64.56M |
64.56M |
64.61M |
Normalized Net Operating Profit after Tax (NOPAT) |
|
-33 |
73 |
84 |
-16 |
92 |
Normalized NOPAT Margin |
|
0.00% |
44.97% |
45.49% |
0.00% |
42.92% |
Pre Tax Income Margin |
|
0.00% |
64.24% |
64.99% |
0.00% |
61.31% |
Debt Service Ratios |
|
- |
- |
- |
- |
- |
EBIT to Interest Expense |
|
-0.75 |
2.04 |
2.29 |
-0.29 |
1.77 |
NOPAT to Interest Expense |
|
-0.52 |
2.04 |
2.29 |
-0.21 |
1.77 |
EBIT Less CapEx to Interest Expense |
|
-0.75 |
2.04 |
2.29 |
-0.29 |
1.77 |
NOPAT Less CapEx to Interest Expense |
|
-0.52 |
2.04 |
2.29 |
-0.21 |
1.77 |
Payout Ratios |
|
- |
- |
- |
- |
- |
Dividend Payout Ratio |
|
-181.94% |
83.81% |
73.32% |
-422.60% |
86.57% |
Augmented Payout Ratio |
|
-181.94% |
83.81% |
73.32% |
-422.60% |
86.57% |
Quarterly Metrics And Ratios for Bain Capital Specialty Finance
This table displays calculated financial ratios and metrics derived from Bain Capital Specialty Finance's official financial filings.
Metric |
|
Q4 2022 |
Q1 2023 |
Q2 2023 |
Q3 2023 |
Q4 2023 |
Q1 2024 |
Q2 2024 |
Q3 2024 |
Q4 2024 |
Q1 2025 |
Q2 2025 |
Growth Metrics |
|
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
Revenue Growth |
|
0.00% |
-119.86% |
6.58% |
-282.04% |
-127.99% |
2,261.24% |
-7.60% |
250.07% |
287.08% |
-149.90% |
-23.74% |
EBITDA Growth |
|
0.00% |
-151.19% |
49.83% |
-343.27% |
-126.38% |
725.68% |
-24.26% |
182.02% |
291.05% |
-189.79% |
-31.26% |
EBIT Growth |
|
0.00% |
-141.96% |
50.72% |
-340.19% |
-126.25% |
843.10% |
-25.00% |
182.91% |
293.55% |
-187.43% |
-31.67% |
NOPAT Growth |
|
0.00% |
-129.37% |
38.07% |
-268.14% |
-119.01% |
1,161.57% |
-25.00% |
218.44% |
376.50% |
-161.20% |
-31.67% |
Net Income Growth |
|
0.00% |
-141.96% |
114.09% |
-340.19% |
-123.70% |
843.10% |
-25.00% |
182.91% |
293.55% |
-187.43% |
-31.67% |
EPS Growth |
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
22.22% |
0.00% |
-1.92% |
-30.61% |
-20.00% |
-17.78% |
Operating Cash Flow Growth |
|
-8.75% |
57.78% |
95.08% |
222.69% |
135.81% |
-48.26% |
2,293.15% |
-211.07% |
-113.44% |
88.59% |
-99.66% |
Free Cash Flow Firm Growth |
|
0.00% |
0.00% |
0.00% |
-22,845.60% |
0.00% |
102.69% |
112.66% |
103.43% |
-206.68% |
-275.51% |
-212.17% |
Invested Capital Growth |
|
0.00% |
0.00% |
0.00% |
55,210.25% |
-4.37% |
-1.15% |
-11.43% |
-2.22% |
5.75% |
3.82% |
16.63% |
Revenue Q/Q Growth |
|
435.79% |
-102.82% |
1,967.06% |
-164.54% |
17.63% |
317.76% |
-20.17% |
4.81% |
2.68% |
-158.09% |
221.88% |
EBITDA Q/Q Growth |
|
328.84% |
-109.22% |
690.83% |
-204.12% |
53.50% |
318.71% |
-28.48% |
12.76% |
8.32% |
-202.79% |
154.68% |
EBIT Q/Q Growth |
|
329.56% |
-107.84% |
800.59% |
-201.74% |
53.05% |
322.04% |
-29.29% |
12.48% |
9.61% |
-200.30% |
155.18% |
NOPAT Q/Q Growth |
|
315.22% |
-105.68% |
1,100.84% |
-171.22% |
53.05% |
417.20% |
-29.29% |
12.48% |
9.61% |
-170.21% |
178.82% |
Net Income Q/Q Growth |
|
375.93% |
-107.08% |
800.59% |
-201.74% |
53.05% |
322.04% |
-29.29% |
12.48% |
9.61% |
-200.30% |
155.18% |
EPS Q/Q Growth |
|
0.00% |
0.00% |
0.00% |
15.56% |
-5.77% |
12.24% |
-18.18% |
13.33% |
-33.33% |
29.41% |
-15.91% |
Operating Cash Flow Q/Q Growth |
|
163.25% |
-168.13% |
79.58% |
1,494.01% |
21.56% |
-142.83% |
402.14% |
-170.60% |
85.29% |
63.63% |
108.89% |
Free Cash Flow Firm Q/Q Growth |
|
-100.00% |
0.00% |
-1.81% |
2.09% |
103.84% |
-29.74% |
379.39% |
-73.45% |
-219.30% |
-15.58% |
-206.34% |
Invested Capital Q/Q Growth |
|
55,186.06% |
1.10% |
3.41% |
-4.31% |
-4.41% |
4.50% |
-7.34% |
5.64% |
3.38% |
2.60% |
4.08% |
Profitability Metrics |
|
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
EBITDA Margin |
|
66.08% |
0.00% |
68.38% |
0.00% |
0.00% |
62.56% |
56.05% |
60.30% |
63.61% |
0.00% |
50.50% |
EBIT Margin |
|
66.38% |
0.00% |
69.30% |
0.00% |
0.00% |
63.50% |
56.24% |
60.35% |
64.42% |
0.00% |
50.36% |
Profit (Net Income) Margin |
|
73.54% |
0.00% |
69.30% |
0.00% |
0.00% |
63.50% |
56.24% |
60.35% |
64.42% |
0.00% |
50.36% |
Tax Burden Percent |
|
114.62% |
100.00% |
100.00% |
100.00% |
100.00% |
100.00% |
100.00% |
100.00% |
100.00% |
100.00% |
100.00% |
Interest Burden Percent |
|
96.66% |
100.00% |
100.00% |
100.00% |
100.00% |
100.00% |
100.00% |
100.00% |
100.00% |
100.00% |
100.00% |
Effective Tax Rate |
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
Return on Invested Capital (ROIC) |
|
4.73% |
0.00% |
9.03% |
0.00% |
0.00% |
1.32% |
1.10% |
3.27% |
5.64% |
0.00% |
2.23% |
ROIC Less NNEP Spread (ROIC-NNEP) |
|
5.41% |
0.00% |
9.03% |
0.00% |
0.00% |
1.32% |
1.10% |
3.27% |
5.64% |
0.00% |
2.23% |
Return on Net Nonoperating Assets (RNNOA) |
|
6.71% |
0.00% |
11.94% |
0.00% |
0.00% |
1.55% |
1.29% |
3.83% |
6.55% |
0.00% |
2.68% |
Return on Equity (ROE) |
|
11.44% |
0.00% |
20.97% |
0.00% |
-2.09% |
2.87% |
2.39% |
7.10% |
12.19% |
0.00% |
4.91% |
Cash Return on Invested Capital (CROIC) |
|
5.32% |
0.00% |
0.00% |
0.00% |
3.79% |
1.98% |
12.59% |
5.49% |
-0.23% |
-1.45% |
-13.36% |
Operating Return on Assets (OROA) |
|
4.74% |
0.00% |
4.41% |
0.00% |
0.00% |
1.28% |
1.06% |
3.17% |
5.43% |
0.00% |
2.16% |
Return on Assets (ROA) |
|
5.25% |
0.00% |
4.41% |
0.00% |
0.00% |
1.28% |
1.06% |
3.17% |
5.43% |
0.00% |
2.16% |
Return on Common Equity (ROCE) |
|
11.79% |
0.00% |
20.97% |
0.00% |
-2.09% |
2.87% |
2.39% |
7.10% |
12.19% |
0.00% |
4.91% |
Return on Equity Simple (ROE_SIMPLE) |
|
0.00% |
9.09% |
10.80% |
6.04% |
0.00% |
1.83% |
1.02% |
7.00% |
0.00% |
5.13% |
4.38% |
Net Operating Profit after Tax (NOPAT) |
|
65 |
-3.69 |
37 |
-26 |
-12 |
39 |
28 |
31 |
34 |
-24 |
19 |
NOPAT Margin |
|
64.16% |
0.00% |
69.30% |
0.00% |
0.00% |
63.50% |
56.24% |
60.35% |
64.42% |
0.00% |
50.36% |
Net Nonoperating Expense Percent (NNEP) |
|
-0.68% |
0.23% |
0.00% |
1.64% |
0.40% |
0.00% |
0.00% |
0.00% |
0.00% |
0.73% |
0.00% |
SG&A Expenses to Revenue |
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
Operating Expenses to Revenue |
|
33.62% |
0.00% |
30.70% |
0.00% |
0.00% |
36.50% |
43.76% |
39.65% |
35.58% |
0.00% |
49.64% |
Earnings before Interest and Taxes (EBIT) |
|
67 |
-5.27 |
37 |
-38 |
-18 |
39 |
28 |
31 |
34 |
-34 |
19 |
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA) |
|
67 |
-6.16 |
36 |
-38 |
-18 |
39 |
28 |
31 |
34 |
-35 |
19 |
Valuation Ratios |
|
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
Price to Book Value (P/BV) |
|
0.54 |
0.53 |
0.64 |
0.74 |
0.75 |
0.80 |
0.85 |
0.89 |
0.97 |
0.94 |
0.86 |
Price to Tangible Book Value (P/TBV) |
|
0.54 |
0.53 |
0.64 |
0.74 |
0.75 |
0.80 |
0.85 |
0.89 |
0.97 |
0.94 |
0.86 |
Price to Revenue (P/Rev) |
|
3.25 |
3.71 |
4.24 |
7.17 |
0.00 |
17.43 |
20.20 |
7.58 |
5.11 |
8.73 |
8.77 |
Price to Earnings (P/E) |
|
5.68 |
7.06 |
7.09 |
17.26 |
0.00 |
54.06 |
58.06 |
11.63 |
9.22 |
21.40 |
21.80 |
Dividend Yield |
|
14.88% |
14.81% |
13.06% |
11.83% |
12.15% |
8.87% |
8.76% |
8.57% |
8.09% |
11.02% |
14.96% |
Earnings Yield |
|
17.62% |
14.16% |
14.11% |
5.80% |
0.00% |
1.85% |
1.72% |
8.59% |
10.85% |
4.67% |
4.59% |
Enterprise Value to Invested Capital (EV/IC) |
|
0.75 |
0.77 |
0.80 |
0.85 |
0.84 |
0.86 |
0.89 |
0.92 |
0.95 |
0.95 |
0.88 |
Enterprise Value to Revenue (EV/Rev) |
|
10.24 |
11.69 |
12.25 |
18.09 |
0.00 |
41.14 |
42.80 |
16.88 |
11.12 |
20.00 |
21.33 |
Enterprise Value to EBITDA (EV/EBITDA) |
|
15.90 |
19.42 |
18.53 |
35.83 |
0.00 |
110.55 |
194.62 |
28.43 |
18.29 |
42.59 |
48.33 |
Enterprise Value to EBIT (EV/EBIT) |
|
15.76 |
19.15 |
18.25 |
34.63 |
0.00 |
102.93 |
177.10 |
28.18 |
18.13 |
41.89 |
47.54 |
Enterprise Value to NOPAT (EV/NOPAT) |
|
15.76 |
19.15 |
18.62 |
35.94 |
0.00 |
102.93 |
177.10 |
28.18 |
18.13 |
41.89 |
47.54 |
Enterprise Value to Operating Cash Flow (EV/OCF) |
|
0.00 |
0.00 |
0.00 |
15.86 |
9.12 |
10.82 |
5.16 |
15.98 |
0.00 |
83.83 |
0.00 |
Enterprise Value to Free Cash Flow (EV/FCFF) |
|
0.00 |
0.00 |
0.00 |
0.00 |
21.54 |
43.07 |
6.64 |
16.65 |
0.00 |
0.00 |
0.00 |
Leverage & Solvency |
|
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
Debt to Equity |
|
1.24 |
1.21 |
1.32 |
1.21 |
1.11 |
1.19 |
1.03 |
1.13 |
1.22 |
1.27 |
1.37 |
Long-Term Debt to Equity |
|
1.24 |
1.21 |
1.32 |
1.21 |
1.11 |
1.19 |
1.03 |
1.13 |
1.22 |
1.27 |
1.37 |
Financial Leverage |
|
1.24 |
1.16 |
1.32 |
1.21 |
1.17 |
1.18 |
1.17 |
1.17 |
1.16 |
1.23 |
1.20 |
Leverage Ratio |
|
2.33 |
2.23 |
2.38 |
2.27 |
2.25 |
2.24 |
2.24 |
2.24 |
2.24 |
2.28 |
2.27 |
Compound Leverage Factor |
|
2.25 |
2.23 |
2.38 |
2.27 |
2.25 |
2.24 |
2.24 |
2.24 |
2.24 |
2.28 |
2.27 |
Debt to Total Capital |
|
55.37% |
54.65% |
56.96% |
54.75% |
52.50% |
54.30% |
50.68% |
53.15% |
54.95% |
55.91% |
57.84% |
Short-Term Debt to Total Capital |
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
Long-Term Debt to Total Capital |
|
55.37% |
54.65% |
56.96% |
54.75% |
52.50% |
54.30% |
50.68% |
53.15% |
54.95% |
55.91% |
57.84% |
Preferred Equity to Total Capital |
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
Noncontrolling Interests to Total Capital |
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
Common Equity to Total Capital |
|
44.63% |
45.35% |
43.04% |
45.25% |
47.50% |
45.70% |
49.32% |
46.85% |
45.05% |
44.09% |
42.16% |
Debt to EBITDA |
|
11.67 |
14.01 |
13.23 |
23.16 |
-49.67 |
69.90 |
110.84 |
16.34 |
10.62 |
25.14 |
31.82 |
Net Debt to EBITDA |
|
10.86 |
13.26 |
12.12 |
21.62 |
-45.47 |
63.70 |
102.78 |
15.66 |
9.88 |
24.00 |
28.46 |
Long-Term Debt to EBITDA |
|
11.67 |
14.01 |
13.23 |
23.16 |
-49.67 |
69.90 |
110.84 |
16.34 |
10.62 |
25.14 |
31.82 |
Debt to NOPAT |
|
11.57 |
13.81 |
13.29 |
23.24 |
-76.26 |
65.07 |
100.86 |
16.20 |
10.53 |
24.73 |
31.30 |
Net Debt to NOPAT |
|
10.76 |
13.08 |
12.18 |
21.69 |
-69.82 |
59.31 |
93.52 |
15.52 |
9.80 |
23.61 |
28.00 |
Long-Term Debt to NOPAT |
|
11.57 |
13.81 |
13.29 |
23.24 |
-76.26 |
65.07 |
100.86 |
16.20 |
10.53 |
24.73 |
31.30 |
Noncontrolling Interest Sharing Ratio |
|
-3.09% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
Liquidity Ratios |
|
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
Cash Flow Metrics |
|
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
Free Cash Flow to Firm (FCFF) |
|
0.00 |
-2,533 |
-2,579 |
-2,525 |
97 |
68 |
327 |
87 |
-103 |
-120 |
-366 |
Operating Cash Flow to CapEx |
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
Free Cash Flow to Firm to Interest Expense |
|
0.00 |
-129.55 |
-126.03 |
-121.52 |
5.04 |
3.77 |
18.52 |
4.79 |
-4.95 |
-6.32 |
-16.82 |
Operating Cash Flow to Interest Expense |
|
2.31 |
-2.20 |
-0.43 |
5.89 |
7.73 |
-3.53 |
10.91 |
-7.50 |
-0.96 |
-0.38 |
0.03 |
Operating Cash Flow Less CapEx to Interest Expense |
|
2.31 |
-2.20 |
-0.43 |
5.89 |
7.73 |
-3.53 |
10.91 |
-7.50 |
-0.96 |
-0.38 |
0.03 |
Efficiency Ratios |
|
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
Asset Turnover |
|
0.07 |
0.06 |
0.06 |
0.09 |
0.00 |
0.02 |
0.02 |
0.05 |
0.08 |
0.05 |
0.04 |
Fixed Asset Turnover |
|
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
Capital & Investment Metrics |
|
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
Invested Capital |
|
2,502 |
2,529 |
2,615 |
2,503 |
2,392 |
2,500 |
2,316 |
2,447 |
2,530 |
2,596 |
2,702 |
Invested Capital Turnover |
|
0.07 |
0.13 |
0.13 |
0.09 |
0.00 |
0.02 |
0.02 |
0.05 |
0.09 |
0.05 |
0.04 |
Increase / (Decrease) in Invested Capital |
|
0.00 |
2,529 |
2,615 |
2,498 |
-109 |
-29 |
-299 |
-56 |
138 |
96 |
385 |
Enterprise Value (EV) |
|
1,888 |
1,953 |
2,087 |
2,119 |
2,000 |
2,147 |
2,061 |
2,263 |
2,394 |
2,458 |
2,373 |
Market Capitalization |
|
599 |
619 |
722 |
840 |
850 |
910 |
973 |
1,017 |
1,101 |
1,073 |
976 |
Book Value per Share |
|
$17.29 |
$18.10 |
$17.44 |
$17.54 |
$17.60 |
$17.70 |
$17.70 |
$17.76 |
$17.65 |
$17.71 |
$17.56 |
Tangible Book Value per Share |
|
$17.29 |
$18.10 |
$17.44 |
$17.54 |
$17.60 |
$17.70 |
$17.70 |
$17.76 |
$17.65 |
$17.71 |
$17.56 |
Total Capital |
|
2,502 |
2,576 |
2,615 |
2,503 |
2,392 |
2,500 |
2,316 |
2,447 |
2,530 |
2,596 |
2,702 |
Total Debt |
|
1,385 |
1,408 |
1,490 |
1,370 |
1,256 |
1,358 |
1,174 |
1,301 |
1,390 |
1,451 |
1,563 |
Total Long-Term Debt |
|
1,385 |
1,408 |
1,490 |
1,370 |
1,256 |
1,358 |
1,174 |
1,301 |
1,390 |
1,451 |
1,563 |
Net Debt |
|
1,289 |
1,333 |
1,366 |
1,279 |
1,150 |
1,237 |
1,089 |
1,246 |
1,293 |
1,385 |
1,398 |
Capital Expenditures (CapEx) |
|
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
Net Nonoperating Expense (NNE) |
|
-9.49 |
1.58 |
0.00 |
11 |
5.29 |
0.00 |
0.00 |
0.00 |
0.00 |
10 |
0.00 |
Net Nonoperating Obligations (NNO) |
|
1,385 |
1,361 |
1,490 |
1,370 |
1,256 |
1,358 |
1,174 |
1,301 |
1,390 |
1,451 |
1,563 |
Total Depreciation and Amortization (D&A) |
|
-0.30 |
-0.90 |
-0.49 |
-0.37 |
-0.01 |
-0.58 |
-0.09 |
-0.03 |
-0.43 |
-0.41 |
0.05 |
Earnings Adjustments |
|
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
Adjusted Basic Earnings per Share |
|
$0.67 |
$0.45 |
$0.45 |
$0.52 |
$0.49 |
$0.55 |
$0.45 |
$0.51 |
$0.34 |
$0.44 |
$0.37 |
Adjusted Weighted Average Basic Shares Outstanding |
|
64.56M |
64.56M |
64.56M |
64.56M |
64.56M |
64.56M |
64.56M |
64.56M |
64.56M |
64.68M |
64.87M |
Adjusted Diluted Earnings per Share |
|
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.49 |
$0.55 |
$0.45 |
$0.51 |
$0.34 |
$0.44 |
$0.37 |
Adjusted Weighted Average Diluted Shares Outstanding |
|
64.56M |
64.56M |
64.56M |
64.56M |
64.56M |
64.56M |
64.56M |
64.56M |
64.56M |
64.68M |
64.87M |
Adjusted Basic & Diluted Earnings per Share |
|
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.47 |
Adjusted Weighted Average Basic & Diluted Shares Outstanding |
|
64.56M |
64.56M |
64.56M |
64.56M |
64.56M |
64.56M |
64.56M |
64.56M |
64.61M |
64.87M |
64.87M |
Normalized Net Operating Profit after Tax (NOPAT) |
|
45 |
-3.69 |
26 |
-26 |
-12 |
27 |
19 |
22 |
24 |
-24 |
13 |
Normalized NOPAT Margin |
|
44.91% |
0.00% |
48.51% |
0.00% |
0.00% |
44.45% |
39.37% |
42.25% |
45.10% |
0.00% |
35.25% |
Pre Tax Income Margin |
|
64.16% |
0.00% |
69.30% |
0.00% |
0.00% |
63.50% |
56.24% |
60.35% |
64.42% |
0.00% |
50.36% |
Debt Service Ratios |
|
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
EBIT to Interest Expense |
|
2.46 |
-0.27 |
1.80 |
-1.81 |
-0.92 |
2.17 |
1.57 |
1.72 |
1.63 |
-1.81 |
0.87 |
NOPAT to Interest Expense |
|
2.38 |
-0.19 |
1.80 |
-1.26 |
-0.64 |
2.17 |
1.57 |
1.72 |
1.63 |
-1.27 |
0.87 |
EBIT Less CapEx to Interest Expense |
|
2.46 |
-0.27 |
1.80 |
-1.81 |
-0.92 |
2.17 |
1.57 |
1.72 |
1.63 |
-1.81 |
0.87 |
NOPAT Less CapEx to Interest Expense |
|
2.38 |
-0.19 |
1.80 |
-1.26 |
-0.64 |
2.17 |
1.57 |
1.72 |
1.63 |
-1.27 |
0.87 |
Payout Ratios |
|
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
Dividend Payout Ratio |
|
73.32% |
87.39% |
75.39% |
137.70% |
-422.60% |
495.16% |
926.36% |
139.93% |
86.57% |
247.82% |
291.53% |
Augmented Payout Ratio |
|
73.32% |
87.39% |
75.39% |
137.70% |
-422.60% |
495.16% |
926.36% |
139.93% |
86.57% |
247.82% |
291.53% |
Key Financial Trends
Bain Capital Specialty Finance (NYSE: BCSF) has demonstrated a generally stable financial performance over the last several years with some fluctuations in income and capital structure, as evident from the quarterly filings up to Q2 2025.
Positive Financial Trends:
- Net income has shown recovery from negative or lower values in early 2023 to positive net income in the latest quarters, with Q2 2025 reporting a continuing operations net income of $23.7 million.
- Net interest income remains positive and relatively stable, with Q2 2025 showing $32.45 million, supported by strong total interest income near $54.2 million and effective management of interest expense at $21.8 million.
- Total assets have increased steadily from about $2.6 billion in early 2023 to about $2.77 billion as of Q2 2025, indicating growth in the company's asset base.
- Issuance of debt continues to support financing activities, with Q2 2025 showing $300 million issued, helping manage liquidity and capital structure effectively.
- Operating cash flow improved to a positive $646,000 in Q2 2025, a turnaround from previous quarters with negative operating cash flow, indicating improving operational cash generation.
- Dividends paid remain consistent, with about $29 million paid out in Q2 2025, reflecting the company's commitment to shareholder returns.
Neutral Financial Aspects:
- Non-cash adjustments and changes in operating assets and liabilities fluctuate significantly each quarter, making cash flow patterns somewhat volatile but typical of financial holding companies.
- Restricted cash levels remain high, around $137 million in Q2 2025, which impacts liquidity but may be required for regulatory or contractual reasons.
- The company maintains a substantial level of long-term debt, about $1.56 billion in Q2 2025, aligning with its business model but requiring careful interest cost management.
Negative Financial Trends and Risks:
- Net realized and unrealized capital losses have impacted income, with a $11.75 million loss in Q2 2025, which can create earnings volatility.
- The company experienced highly negative revenue and net income in Q1 2025 (net loss continuing operations of $34.2 million), indicating possible challenges in that quarter's performance before a recovery phase.
- Operating cash flows were significantly negative in several quarters during 2023 and 2024, showing periods of operational cash generation weakness or investments requiring cash outflows.
Summary:
Overall, Bain Capital Specialty Finance has transitioned towards improved earnings and operational cash flow in recent quarters, after facing some setbacks. The company's strong asset base and maintained dividend payout signal business stability. However, the reliance on debt financing and volatile investment gains/losses pose risks to consistent profitability. Investors should monitor future quarters for continued operational cash flow improvement and capital gains stabilization.
10/03/25 06:31 AM ETAI Generated. May Contain Errors.